Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

CMS Extends the MIPS 2017 Data Submission Deadline from March 31 to April 3 at 8 PM EDT

If you’re an eligible clinician participating in the Quality Payment Program, you now have until Tuesday, April 3,…

read more

Congress Moves Closer to Close the Books on FY 2018 Appropriations

In a span of 4 days, Congress passed legislation to fund the government through March…

read more

Act Now to Avoid MACRA Penalties

Before the close of 2017, all physicians must take action to avoid the 4 percent…

read more
  • 1
  • 2

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/01/2018: 2018 Fellow Exam Application Deadline
Learn more

06/01/2018: Research Grant Cycle

12/01/2018: Research Grant Cycle
Learn more

07/31/18: Membership Application Deadline to be voted in at the 2018 Annual Meeting
Learn more

EDUCATION

Codes/Guidelines

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Updated Advanced Course

Drs. Damask and Parker will lead the faculty for our annual Advanced Course in Allergy & Immunology that builds on the Basic Course and delves further into allergy diagnosis, management, and treatment.
Read More

Interactive Allergy & Rhinology Course

Course directors, Christine Franzese and Sarah Wise, are excited to announce the 2018 AAOA Interactive Allergy and Rhinology Course.
Read More

IFAR

IFAR Impact Factor: 2.135

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2018 Basic Course in Allergy & Immunology
July 5-7 | Hollywood, FL
Learn More and Register

2018 AAOA Annual Meeting
September 14-16 | Philadelphia, PA
Learn More and Register

2018 Advanced Course in Allergy & Immunology
December 6-8 | Atlanta, GA
Save the Date

AAOA Clinical Insights
Coming Soon!!!

PATIENT CORNER

Avoidance

The first most basic treatment step, once an allergen has been identified, is to eliminate or avoid contact with it, if possible. Unfortunately, avoiding some allergens (such as dust, molds, and animals) is often difficult and thus allergen avoidance alone may not be effective.

Read More

News and Updates

The AAOA Wins Gold in Association TRENDS 2017 All-Media Contest

FOR IMMEDIATE RELEASE Contact: Marina Fassnacht Director of Marketing and Communications 11130 Sunrise Valley Dr.…

read more

Alert: Nationwide Shortage of Sterile Water for Injections

Nationwide shortage of Sterile Water for Injections is affecting multiple manufacturers. Some Specialty Pharmacies are…

read more

Choose the IndependENT 2018 AAOA Annual Meeting!

Building off the success of our radically re-designed Chicago Annual Meeting, we look forward to…

read more
Menu
Flu Nasal Spray 840 420

Allergic Rhinitis and Nasal Sprays

As indicated in our mission statement, the AAOA is concerned with advancing the treatment of patients with allergic disease.  When the FDA was considering making Nasacort available over-the-counter, the AAOA surveyed our membership about the topic.

The biggest concerns expressed were ensuring patients were getting an accurate diagnosis of their nasal problems, were given good information about available treatment options, and that they were being monitored long-term for potential side effects of medications, such as nasal steroid sprays.

Nasal steroid sprays are a great treatment option for patients with allergic rhinitis. They are generally considered the most effective class of medications available for treating the four major symptoms of allergic rhinitis, particularly nasal obstruction, runny nose, nasal itching, and sneezing. Now that the FDA has approved the over-the-counter availability of Nasacort, we hope that this will make the nasal steroid treatment option more available and affordable for patients with allergic rhinitis. This is what happened after non-sedating antihistamines became available over-the-counter. The AAOA still stresses the importance of patients receiving a good assessment of their nasal problems to make sure the appropriate treatment options are recommended. If nasal steroid sprays appear to be a good option, for some patients it will be more affordable to buy these over-the-counter.  As of now, patients with prescription drug coverage often still get a better price on generic nasal steroid sprays by prescription, compared to purchasing them over-the-counter.  We still recommend the patients have regular examinations of their nose, typically at least once a year, to make sure there are no complications of persistent nasal steroid spray use.

With the approval of Nasacort, more nasal steroid sprays are likely to become available over the counter. The FDA has already approved the Flonase brand for over-the-counter availability. It has been reported online that Flonase will likely become available in stores over-the-counter in early 2015. As multiple nasal steroid sprays become available over-the-counter, it is possible generic brands will also become available, and hopefully competition will result in lower prices.

 

Leave a Reply

Your email address will not be published. Required fields are marked *